Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the efficacy and safety of EGb 761® in patients with
the primary Raynaud phenomenon, with regards to the frequency, duration and severity of
vasospastic attacks.